Blue Horseshoe Stocks: Stellar Options Calls & More

Valeant Pharmaceuticals, Inc. VRX – Options Recap

In yesterday morning’s premarket report, we noted that VRX had been coming off of recent annual lows, had a beat on earnings, and was up considerably in early trading.

Our exact words were “We want to formulate an options idea to coincide with the increased activity and expected price action in a stock in this position. We’ve seen this sort of pattern many times before, and if things play out similarly here, the VRX Weekly $10.50-12 Calls could be in line to see considerable gains.” Things did play out similarly. We did indeed see considerable gains, and quite frankly, that’s an understatement.

As VRX itself traded from 10.57 to 12.43, our targeted options calls posted astronomical moves on the day, giving traders a chance to grab a piece of the following gains:

$10.50 Calls – Range: .40-.1.92 – Max Gain: 380%
$11 Calls – Range: .18-1.50 – Max Gain: 733%
$11.50 Calls – Range: .08-1.05 – Max Gain: 1212%
$12 Calls – Range: .02-.74 – Max Gain: 3600%

This wasn’t even the first percentage gain in the thousands that we’ve rooted out in the past week. The SPY Weekly $238-50-239.50 Calls that we highlighted in Friday morning’s premarket report yielded a 4600% gainer on that day. Both of these plays serve as perfect examples of why we don’t limit our daily reports to stocks alone.


Cleantech Solutions International, Inc. CLNT

We did have a very nice play on the stock side of things as well yesterday, after we tagged CLNT in our extended watchlist. It ended up making a solid early push from a low of 4.11, and ran as high as 6.99 inside the first hour of trading.

That was good for intraday gains of up to 70% which we feel is quite good for a stock in this price range. CLNT is pulling back in premarket, but we will remain interested in possible bounce activity in the event that it holds support above yesterday’s swing low.



Proteon Therapeutics, Inc. PRTO

There’s an interesting situation unfolding with PRTO that warrants placing the stock on watch today. Despite reporting Q1 losses of $6.5M, the stock is gapping up heavily on the strength of a concurrent announcement. It pertains to the fact that the company’s investigatory treatment, vonapanitase, has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA).

Whenever such FDA news hits wires the resultant activity on the chart is sure to be interesting, which is evidenced by the the fact that traders are ignoring the disappointing quarterly figures that coincided with this event. Thus we are eager to track PRTO as we head through midweek.


Extended Watchlist:
ASTI, BZUN, LBIO, AAXN, ARGS, MTBC, REXX

Blue Horseshoe Stocks: ASTI, TEUFF Reviews & More

Ascent Solar Technologies, Inc. ASTI

We’ve been quite familiar with ASTI in the past, and circled back around to it yesterday morning, in time to catch what was ultimately one heck of a solid session.

We had noticed it recently producing some bottom-bounce action, along with a huge increase in volume and they proved to be huge indicators of a continued surge. The stock traded in a range from .051-.0779, for a healthy 53% jump, and maintained well over half of that gain into the close at .074.

We’ll definitely want to see ASTI take a run at its previous swing highs of .085 and .119, followed by the 50DMA of .13, as pointed out in the chart snapshot here:


Time Warner, Inc. TWX – Options Update

We brought an options trading idea to the table yesterday morning in the wake of an earnings beat for Time Warner, the TWX Weekly $77-79 Calls, and every set of contracts in the range performed really well, with each one yielding a multi-bag gain opportunity on the day.

$77 Calls – Range: .76-2.06 – Max Gain: 171%
$77.50 Calls – Range: .59-1.57 – Max Gain: 166%
$78 Calls – Range: .37-1.37 – Max Gain: 270%
$78.50 Calls – Range: .20-.65 – Max Gain: 225%
$79 Calls – Range: .09-.69 – Max Gain: 422%

With news hitting in the post-market yesterday that TWX will be taking up a 10% stake in Hulu, it will be interesting to see how the activity unfolds from here.


Box Ships, Inc. TEUFF

Another inclusion in yesterday’s premarket report was TEUFF, which, similar to ASTI, was in the midst of a spike in upward momentum off of a recent bottom. We were banking on seeing some of that carry over into yesterday’s session, and that’s just what happened.

TEUFF traded up from a low of .018 and hit .0276; another 53% intraday gainer for what was a very productive day all around.


Extended Watchlist:
APHB, GMEV, OCUL, LEXG, MJMI, DNRG(Potential bottom)

Incoming search terms:

  • asti 100 bagger

Blue Horseshoe Stocks: AGTK Recap, Options & More

Agritek Holdings, Inc. AGTK

The standout runner from yesterday morning’s premarket report ended up being AGTK. We noticed it had been ramping up in PPS over the preceding two sessions, and figured it was worth tracking. We were right on in our assumption, as the stock traded in a respectable daily range, running into the close with strength.

AGTK saw an early low of .00168 before running to a high of .0025, representing a single-session spike of 49% The move came on stronger-than-average volume, and marked the third straight session of higher highs and higher lows.

We’ll remain interested in tracking the activity in AGTK provided it can hold support at or above .002; next key areas of resistance are at the 50 and 200DMA’s at .0029 and .0031, respectively.


Options Ideas:

We’ve got a pair of options chains to watch as well, for the following ideas:

Ford Motor Co. F – Our idea concerning Ford is based more off of technical factors of the current chart. As you can see, there are a number of indicators pointing to the possibility of a forthcoming recovery. We want to select a set of contracts with an extended expiration to give our idea time to manifest; the F 09/16 $12.75 Calls. The stock is searching for a bottom, and we’ll need to wait until just the right moment when it begins to rebound and possibly make a run at filling the gap.


______

Time Warner, Inc. TWX – The other plays we’re going to be keeping an eye on are short term, weekly expiration ideas: TWX Weekly $77-79 Calls.


Odyssey Marine Exploration, Inc. OMEX

Lastly, we want to put another new play on watch, based purely off of the look of the chart. As you can see, OMEX is in the process of filling a major gap on its chart from this spring, and it just bulled through its 200DMA yesterday. The RSI has also cracked into the power zone, so we’ll definitely be observing the near-term activity on this play.


Extended Watchlist:
ASTI, COSI, TEUFF, MGT, PTX, SHIP, GLBS

Blue Horseshoe Stocks: PLCE Options Recap & More

The Children’s Place, Inc. PLCE – Options Review

The first thing we want to mention this morning is the performance our running options idea for PLCE that we formulated earlier in the week. We continued to stay on the trail of PLCE Weekly $70-75 Calls in yesterday’s premarket report, even after they had provided us with chances at gains ranging from 112-315% in the prior session.

Despite the $75′s being a bit too far out of the money for any notable action, the other two contracts from within our target sets performed solidly once again.

The $70 Calls traded in a daily range from 2.85-3.70, which marked an intraday rise of 30% The $72.50′s fared even better, running from a low of .65 to a high of 1.30, marking an even 100% rip and the second consecutive session wherein the stock provided the opportunity at at least a double-bagger.


Immunomedics, Inc. IMMU

We tagged IMMU for observation on Friday of last week, and since that time the stock has made an appreciable swing to the upside. Our observed low on the stock is 3.59, which gave way to a new high of 4.25 yesterday. That represents a modest yet notable 18% increase.

We’ll want to continue to monitor the activity in this play which will hold our interest moving forward, provided it can maintain support at or above its previous resistance point of 4.00 on any pullbacks.

MORRIS PLAINS, N.J., May 19, 2016 (GLOBE NEWSWIRE) — Immunomedics, Inc. (Nasdaq:IMMU) today announced that the Scientific Program Committee of the American Society of Clinical Oncology (ASCO) has selected two of the Company’s abstracts for oral presentation at two Clinical Science Symposium Sessions during their 2016 Annual Meeting, scheduled for June 3-7, 2016 at McCormick Place Convention Center in Chicago, Illinois. (>>View PR)


Global Equity International, Inc. GEQU

GEQU has proven to be a solid winner for us in the past. We recently re-tagged it at a perfect time on 11th of this month, just as it was coming off a bottom. We saw the stock  trading as low as .0123 yesterday it closed at a new high of .03, which goes down as a 144% swing.

We’ll keep our eyes on this one as well, in the event it can maintain support above the 200DMA of .0235.


Extended Watchlist:
UAMM, ASTI, NWMH, TTCM, FDIT

Blue Horseshoe Stocks: Options Review, Other Updates

Options Review

Just to refresh our readers’ memories, we highlighted a range of call contracts for three separate plays on Friday, and we’re pleased to report that sizable gains were there for the taking regardless of which idea was chosen. It marked the continuation of a flawless streak of such ideas that we offered up over the past few weeks.

Our tracked calls and the magnitude of the gains that were available were as follows:

SPDR S&P 500 (SPY) Weekly $199-202 Calls – We’ve successfully played the SPY so many times it doesn’t even bear counting, and Friday was no different. From the low end of our range to the high, gains of 80-427% were made.

Finisar Corp FNSR Weekly $15 and $16 Calls – An earnings beat made the gains in FNSR calls possible, with the $15′s running 88%, and the $16′s making a 92% upswing.

Ulta Salon, Cosmetics & Fragrance, Inc. ULTA  Weekly $175-185 Calls -  Last but not least, we had the ULTA contracts on our watchlist bank gains running from 59-117%

Again, it was yet another great week for options, and we’ll be doing everything in our power to keep the streak alive with some more ideas this week so be sure to stay tuned!


Friday’s Stock Gainers

In addition to our great success with options plays from Friday’s morning report, we had a number of other intraday movers which were also highlighted.

Propanc Health Group Corp. PPCH

This was our top-billed mention on Friday, having been following it for most of last week. A string of solid performances led the stock on a great intraweek run to that point which spanned from our observed low of .0188 to .037 (+97%) in just a few sessions.

We saw even more gains tacked on there during Friday’s trading, wherein we witnessed another nice intraday pop from the daily low of .0355 to .0516 (+45%), and the high extended our total observed range to an impressive 174% in a matter of four sessions.

_____

Mexus Gold US (MXSG)

Mexus was another point of discussion in Friday’s newsletter, and it too saw appreciable gains on the day.

We’d already been very familiar with the stock after tracking over a more than 1000% move in early February. We then re-tagged it the Wednesday before last and subsequently witnessed a 61% swing from .011-.018.

Friday’s session brought a continuation of that run from .017 to a high of .0299, a 71% intraday rip, and increased the total swing range to 172%

_____

Spectrascience, Inc. SCIE

SCIE was included in Friday’s tracklist and the stock would end up trading in a range from .003 to .0047, for total possible intraday gains of up to 56% on slightly heavier than normal volume.

It also managed to close just a tick below the high of day, so we’ll keep an eye peeled for the possibility of momentum spillover into this new trading week.


GW Pharmaceuticals, Inc. GWPH

We want to pin GWPH to our tracklist after catching a significant PR coming across the wires this morning. Late-stage studies on a cannabidiol (CBD) treatment of a rare pediatric disease has yielded positive results, and the stock has thus far gapped up over 100% in the premarket.

We’ll take our classic stance of monitoring for a possible dip-and-rip situation and look to get positioned in some in-the-money Calls, dependent upon where the bounce occurs.

LONDON, March 14, 2016 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (GWPH) (GWP.L) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces the positive results of the first pivotal Phase 3 study of its investigational medicine Epidiolex® (cannabidiol or CBD) for the treatment of Dravet syndrome. (>> FULL PR)


Extended Watchlist:
DDD, TFM, GBIM, HPTG, USAR, IEEC, ASTI, SVTE